BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Lindsay M. Urben, Jennifer Wiedmar, Erica Boettcher, Rodrigo Cavallazzi, Robert G. Martindale, Stephen A. McClave. Bugs or Drugs: Are Probiotics Safe for Use in the Critically Ill?Current Gastroenterology Reports 2014; 16(7) doi: 10.1007/s11894-014-0388-y
2
Vincent Cascio, Daniel Gittings, Kristen Merloni, Matthew Hurton, David Laprade, Nicanor Austriaco. S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii,from acid-induced cell deathBMC Microbiology 2013; 13(1) doi: 10.1186/1471-2180-13-35
3
Shu Guowei, Xin Yang, Chen Li, Dan Huang, Zhangteng Lei, Chen He. Comprehensive optimization of composite cryoprotectant for Saccharomyces boulardii during freeze-drying and evaluation of its storage stabilityPreparative Biochemistry & Biotechnology 2019; 49(9): 846 doi: 10.1080/10826068.2019.1630649
4
Evie H. Carchman, Andrew B. Peitzman, Richard L. Simmons, Brian S. Zuckerbraun. The role of acute care surgery in the treatment of severe, complicated Clostridium difficile–associated diseaseJournal of Trauma and Acute Care Surgery 2012; 73(4): 789 doi: 10.1097/TA.0b013e318265d19f
5
Sonia S. Yoon, Jun Sun. Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory PathwaysGastroenterology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/971938
6
Xin Yang, Guowei Shu, Zhangteng Lei, Guanli Du, Zemin Liu, Jili Cao. Effect of Carbon Sources, Nitrogen Sources and Prebiotics on Growth of Saccharomyces Boulardii Acta Universitatis Cibiniensis. Series E: Food Technology 2019; 23(2): 101 doi: 10.2478/aucft-2019-0013
7
D. Dutta, F. Jafri, D. Stuhr, B. M. Knoll, S. H. Lim. A contemporary review of Clostridioides difficile infections in patients with haematologic diseases Journal of Internal Medicine 2021; 289(3): 293 doi: 10.1111/joim.13173
8
Roshanak Sambrani, Jalal Abdolalizadeh, Leila Kohan, Behboud Jafari. Recent advances in the application of probiotic yeasts, particularly Saccharomyces, as an adjuvant therapy in the management of cancer with focus on colorectal cancerMolecular Biology Reports 2021; 48(1): 951 doi: 10.1007/s11033-020-06110-1
9
Massimo Iorizzo, Francesca Coppola, Francesco Letizia, Bruno Testa, Elena Sorrentino. Role of Yeasts in the Brewing Process: Tradition and InnovationProcesses 2021; 9(5): 839 doi: 10.3390/pr9050839
10
Timothy D. H. Woo, Kentaro Oka, Motomichi Takahashi, Fuhito Hojo, Takako Osaki, Tomoko Hanawa, Satoshi Kurata, Hideo Yonezawa, Shigeru Kamiya. Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain Journal of Medical Microbiology 2011; 60(11): 1617 doi: 10.1099/jmm.0.033423-0
11
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterologíaRevista de Gastroenterología de México 2017; 82(2): 156 doi: 10.1016/j.rgmx.2016.08.004
12
Jonathan Takahashi, J. Adam Rindfleisch. Integrative Medicine2018; : 986 doi: 10.1016/B978-0-323-35868-2.00105-5
13
Pietro Pozzoni, Alessia Riva, Alessandro Giacco Bellatorre, Maria Amigoni, Elena Redaelli, Anna Ronchetti, Mariangela Stefani, Rosangela Tironi, Edoardo Ennio Molteni, Dario Conte, Giovanni Casazza, Agostino Colli. Saccharomyces boulardii for the Prevention of Antibiotic-Associated Diarrhea in Adult Hospitalized Patients: A Single-Center, Randomized, Double-Blind, Placebo-Controlled TrialAmerican Journal of Gastroenterology 2012; 107(6): 922 doi: 10.1038/ajg.2012.56
14
Luis Vitetta, Emma Saltzman, Tessa Nikov, Isabelle Ibrahim, Sean Hall. Modulating the Gut Micro-Environment in the Treatment of Intestinal ParasitesJournal of Clinical Medicine 2016; 5(11): 102 doi: 10.3390/jcm5110102
15
T. M. Batista, E. T. A. Marques, G. R. Franco, B. Douradinha. Draft Genome Sequence of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii Strain ATCC MYA-796Genome Announcements 2014; 2(6) doi: 10.1128/genomeA.01345-14
16
Monika E. Jach, Anna Serefko. Diet, Microbiome and Health2018; : 237 doi: 10.1016/B978-0-12-811440-7.00009-0
17
Judit Villar-García, Juan J. Hernández, Robert Güerri-Fernández, Alicia González, Elisabet Lerma, Ana Guelar, David Saenz, Lluisa Sorlí, Milagro Montero, Juan P. Horcajada, Hernando Knobel Freud. Effect of Probiotics (Saccharomyces boulardii) on Microbial Translocation and Inflammation in HIV-Treated PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes 2015; 68(3): 256 doi: 10.1097/QAI.0000000000000468
18
Pengya Feng, Ze Ye, Apurva Kakade, Amanpreet Virk, Xiangkai Li, Pu Liu. A Review on Gut Remediation of Selected Environmental Contaminants: Possible Roles of Probiotics and Gut MicrobiotaNutrients 2018; 11(1): 22 doi: 10.3390/nu11010022
19
Herbert L. DuPont. Diagnosis and Management of Clostridium difficile InfectionClinical Gastroenterology and Hepatology 2013; 11(10): 1216 doi: 10.1016/j.cgh.2013.03.016
20
Cristiane C.K. Mayerhofer, Ayodeji Awoyemi, Johannes R. Hov, Marius Trøseid, Kaspar Broch. Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failureESC Heart Failure 2019; 6(3): 557 doi: 10.1002/ehf2.12437
21
Stéphanie Blanquet-Diot, Sylvain Denis, Sandrine Chalancon, Fehd Chaira, Jean-Michel Cardot, Monique Alric. Use of Artificial Digestive Systems to Investigate the Biopharmaceutical Factors Influencing the Survival of Probiotic Yeast During Gastrointestinal Transit in HumansPharmaceutical Research 2012; 29(6): 1444 doi: 10.1007/s11095-011-0620-5
22
Nurcan Değirmencioğlu, Ozan Gurbuz, Yasemin Şahan. The Monitoring, Via an In vitro Digestion System, of the Bioactive Content of Vegetable Juice Fermented with Saccharomyces cerevisiae and Saccharomyces boulardii Journal of Food Processing and Preservation 2016; 40(4): 798 doi: 10.1111/jfpp.12704
23
Pei Pei Chong, Voon Kin Chin, Chung Yeng Looi, Won Fen Wong, Priya Madhavan, Voon Chen Yong. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future TherapyFrontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01136
24
Kerry L Ivey, Jonathan M Hodgson, Satvinder S Dhaliwal, Richard J Woodman, Richard L Prince, Kerry L Ivey. Cochrane Database of Systematic Reviews2013;  doi: 10.1002/14651858.CD010445
25
Sarah H. Yi, John A. Jernigan, L. Clifford McDonald. Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitalsAmerican Journal of Infection Control 2016; 44(5): 548 doi: 10.1016/j.ajic.2015.12.001
26
Ana María Gil-Rodríguez, Enriqueta Garcia-Gutierrez. Advances in Applied Microbiology 2021; 114: 37 doi: 10.1016/bs.aambs.2020.11.002
27
Lynne McFarland. Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic ReviewAntibiotics 2015; 4(2): 160 doi: 10.3390/antibiotics4020160
28
Benjamin Offei, Paul Vandecruys, Stijn De Graeve, María R. Foulquié-Moreno, Johan M. Thevelein. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardiiGenome Research 2019; 29(9): 1478 doi: 10.1101/gr.243147.118
29
Bruno K. Rodiño-Janeiro, María Vicario, Carmen Alonso-Cotoner, Roberto Pascua-García, Javier Santos. A Review of Microbiota and Irritable Bowel Syndrome: Future in TherapiesAdvances in Therapy 2018; 35(3): 289 doi: 10.1007/s12325-018-0673-5
30
A. Poncelet, L. Ruelle, D. Konopnicki, V.Y. Miendje Deyi, N. Dauby. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administrationInfectious Diseases Now 2021; 51(3): 293 doi: 10.1016/j.idnow.2020.12.003
31
Naflesia B.O. Corrêa, Francisco J. Penna, Fátima M.L.S. Lima, Jacques R. Nicoli, Luciano A.P. Filho. Treatment of Acute Diarrhea With Saccharomyces boulardii in InfantsJournal of Pediatric Gastroenterology & Nutrition 2011; 53(5): 497 doi: 10.1097/MPG.0b013e31822b7ab0
32
Scientific Opinion on the substantiation of health claims related to Saccharomyces cerevisiae var. boulardii CNCM I‐1079 and defence against pathogenic gastro‐intestinal microorganisms (ID 913, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006EFSA Journal 2012; 10(6) doi: 10.2903/j.efsa.2012.2717
33
Alexa C B Johnson, Heidi A Rossow. Effects of two equine digestive aid supplements on hindgut health1Translational Animal Science 2019; 3(1): 340 doi: 10.1093/tas/txy103
34
Lee E. Morrow, Vijaya Gogineni, Mark A. Malesker. Probiotics in the Intensive Care UnitNutrition in Clinical Practice 2012; 27(2): 235 doi: 10.1177/0884533612440290
35
Eric Wombwell, Mark E Patterson, Bridget Bransteitter, Lisa R Gillen. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile InfectionClinical Infectious Diseases 2020;  doi: 10.1093/cid/ciaa808
36
Carlotta Suardi, Emanuela Cazzaniga, Stephanie Graci, Dario Dongo, Paola Palestini. Link between Viral Infections, Immune System, Inflammation and DietInternational Journal of Environmental Research and Public Health 2021; 18(5): 2455 doi: 10.3390/ijerph18052455
37
Mohammad Abdollahi, Amir Hossein Abdolghaffari, Maziar Gooshe, Farnaz Ghasemi-Niri. Probiotics, Prebiotics, and Synbiotics2016; : 227 doi: 10.1016/B978-0-12-802189-7.00015-0
38
Carolina Hernández-Haro, Silvia Llopis, María Molina, Lucía Monteoliva, Concha Gil. Immunoproteomic profiling of Saccharomyces cerevisiae systemic infection in a murine modelJournal of Proteomics 2015; 112: 14 doi: 10.1016/j.jprot.2014.08.008
39
Xiang Gao, Jingwen Liu, Li Li, Wei Liu, Meiyan Sun. A Brief Review of Nutraceutical Ingredients in Gastrointestinal Disorders: Evidence and SuggestionsInternational Journal of Molecular Sciences 2020; 21(5): 1822 doi: 10.3390/ijms21051822
40
María Velasco, Teresa Requena, Alberto Delgado-Iribarren, Carmen Peláez, Carlos Guijarro. Probiotic Yogurt for the Prevention of Antibiotic-associated Diarrhea in AdultsJournal of Clinical Gastroenterology 2019; 53(10): 717 doi: 10.1097/MCG.0000000000001131
41
Jin-Pei Dong, Yue Zheng, Ting Wu, Qun He, Gui-Gen Teng, Hua-Hong Wang. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in miceChinese Medical Journal 2019; 132(16): 1951 doi: 10.1097/CM9.0000000000000364
42
Sara Khosravi, Razieh Amini, Mohammad Reza Arabestani, Seyed Saman Talebi, Farid Azizi Jalilian. Isolation of a lytic bacteriophage for Helicobacter pyloriGene Reports 2021; 23: 101107 doi: 10.1016/j.genrep.2021.101107
43
Rodolphe Pontier-Bres, Patrick Rampal, Jean-François Peyron, Patrick Munro, Emmanuel Lemichez, Dorota Czerucka. The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT ToxinToxins 2015; 7(11): 4455 doi: 10.3390/toxins7114455
44
Toufic A. Kabbani, Kumar Pallav, Scot E. Dowd, Javier Villafuerte-Galvez, Rohini R. Vanga, Natalia E. Castillo, Joshua Hansen, Melinda Dennis, Daniel A. Leffler, Ciarán P. Kelly. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteersGut Microbes 2017; 8(1): 17 doi: 10.1080/19490976.2016.1267890
45
Flaviano S. Martins, Angélica T. Vieira, Samir D.A. Elian, Rosa M.E. Arantes, Fabiana C.P. Tiago, Lirlândia P. Sousa, Helena R.C. Araújo, Paulo F. Pimenta, Cláudio A. Bonjardim, Jacques R. Nicoli, Mauro M. Teixeira. Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in miceMicrobes and Infection 2013; 15(4): 270 doi: 10.1016/j.micinf.2012.12.007
46
Maria Assunta Zocco, Matteo Garcovich, Antonio Gasbarrini. Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic UseAmerican Journal of Gastroenterology 2012; 107(9): 1441 doi: 10.1038/ajg.2012.222
47
Jean-Marie Vetel, Habib Hamza, Benoît Coffin, Philippe Lehert. Racecadotril Efficacy in the Symptomatic Treatment of Adult Acute Diarrhoea: A Systematic Review and Meta-AnalysisInternational Journal of Clinical Medicine 2014; 5(07): 361 doi: 10.4236/ijcm.2014.57052
48
Sylvia Cruchet, Raquel Furnes, Aldo Maruy, Eduardo Hebel, Jorge Palacios, Fernando Medina, Nelson Ramirez, Marina Orsi, Lysette Rondon, Vera Sdepanian, Luis Xóchihua, Manuel Ybarra, Roberto Arturo Zablah. The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American ExpertsPediatric Drugs 2015; 17(3): 199 doi: 10.1007/s40272-015-0124-6
49
Ming Li, Lin Zhu, Ao Xie, Jieli Yuan. Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial CompositionInflammation 2015; 38(1): 170 doi: 10.1007/s10753-014-0019-7
50
Kate L. Pumpa, Andrew J. McKune, Joanna Harnett. A novel role of probiotics in improving host defence of elite rugby union athlete: A double blind randomised controlled trialJournal of Science and Medicine in Sport 2019; 22(8): 876 doi: 10.1016/j.jsams.2019.03.013
51
Mary Hickson. Probiotics in the prevention of antibiotic-associated diarrhoea andClostridium difficileinfectionTherapeutic Advances in Gastroenterology 2011; 4(3): 185 doi: 10.1177/1756283X11399115
52
Mehdi Goudarzi, Sima Sadat Seyedjavadi, Hossein Goudarzi, Elnaz Mehdizadeh Aghdam, Saeed Nazeri. Clostridium difficileInfection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic OptionsScientifica 2014; 2014: 1 doi: 10.1155/2014/916826
53
Jason C. Sniffen, Lynne V. McFarland, Charlesnika T. Evans, Ellie J. C. Goldstein, Leandro Araujo Lobo. Choosing an appropriate probiotic product for your patient: An evidence-based practical guidePLOS ONE 2018; 13(12): e0209205 doi: 10.1371/journal.pone.0209205
54
Anne Danieli Nascimento Soares, Samuel Penna Wanner, Elissa Stefane Silva Morais, Alexandre Sérvulo Ribeiro Hudson, Flaviano Santos Martins, Valbert Nascimento Cardoso. Supplementation with Saccharomyces boulardii Increases the Maximal Oxygen Consumption and Maximal Aerobic Speed Attained by Rats Subjected to an Incremental-Speed ExerciseNutrients 2019; 11(10): 2352 doi: 10.3390/nu11102352
55
Glenn R. Gibson, Robert J. Brummer, Erika Isolauri, Herbert Lochs, Lorenzo Morelli, Theo Ockhuizen, Ian R. Rowland, Jürgen Schrezenmeir, Catherine Stanton, Kristin Verbeke. The design of probiotic studies to substantiate health claims.Gut Microbes 2011; 2(5): 299 doi: 10.4161/gmic.2.5.18002
56
Ghasem Bagherpour, Hosnie Ghasemi, Bahare Zand, Najmeh Zarei, Farzin Roohvand, Esmat M. Ardakani, Mohammad Azizi, Vahid Khalaj. Oral Administration of Recombinant Saccharomyces boulardii Expressing Ovalbumin-CPE Fusion Protein Induces Antibody Response in MiceFrontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00723
57
Laura Canonico, Emanuele Zannini, Maurizio Ciani, Francesca Comitini. Assessment of non-conventional yeasts with potential probiotic for protein-fortified craft beer productionLWT 2021; 145: 111361 doi: 10.1016/j.lwt.2021.111361
58
Mathias L. Richard, Bruno Lamas, Giuseppina Liguori, Thomas W. Hoffmann, Harry Sokol. Gut Fungal MicrobiotaInflammatory Bowel Diseases 2015; 21(3): 656 doi: 10.1097/MIB.0000000000000261
59
Christine S. Cocanour. Best Strategies in Recurrent or PersistentClostridium difficileInfectionSurgical Infections 2011; 12(3): 235 doi: 10.1089/sur.2010.080
60
Ben‐Gang Zhou, Ling‐Xiao Chen, Bo Li, Lin‐Yan Wan, Yao‐Wei Ai. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis Helicobacter 2019; 24(5) doi: 10.1111/hel.12651
61
Jorge M.B. Vítor, Filipa F. Vale. Alternative therapies for Helicobacter pylori: probiotics and phytomedicineFEMS Immunology & Medical Microbiology 2011; 63(2): 153 doi: 10.1111/j.1574-695X.2011.00865.x
62
Paul M. Coates, Holly Nicastro, John A. Milner. Present Knowledge in Nutrition2012; : 1255 doi: 10.1002/9781119946045.ch73
63
Ashima Vohra, Poonam Syal, Anshu Madan. Probiotic yeasts in livestock sectorAnimal Feed Science and Technology 2016; 219: 31 doi: 10.1016/j.anifeedsci.2016.05.019
64
Hassan Seddik, Hanae Boutallaka, Ilham Elkoti, Fouad Nejjari, Reda Berraida, Sanaa Berrag, Khaoula Loubaris, Sara Sentissi, Ahmed Benkirane. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trialEuropean Journal of Clinical Pharmacology 2019; 75(5): 639 doi: 10.1007/s00228-019-02625-0
65
Gerald Friedman. The Role of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea and Clostridium Difficile ColitisGastroenterology Clinics of North America 2012; 41(4): 763 doi: 10.1016/j.gtc.2012.08.002
66
Lei Yu, Xue-ke Zhao, Ming-liang Cheng, Guo-zhen Yang, Bi Wang, Hua-juan Liu, Ya-xin Hu, Li-li Zhu, Shuai Zhang, Zi-wen Xiao, Yong-mei Liu, Bao-fang Zhang, Mao Mu. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver InjuryScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01271-9
67
Patrice D Cani, Matthias Van Hul. Novel opportunities for next-generation probiotics targeting metabolic syndromeCurrent Opinion in Biotechnology 2015; 32: 21 doi: 10.1016/j.copbio.2014.10.006
68
Heike Stier, Stephan C. Bischoff. Saccharomyces boulardii CNCM I-745 beeinflusst das darmassoziierte ImmunsystemMMW - Fortschritte der Medizin 2017; 159(S5): 1 doi: 10.1007/s15006-017-9802-3
69
Mickaël Alain Fleury, Olivier Le Goff, Sylvain Denis, Frédérique Chaucheyras-Durand, Eric Jouy, Isabelle Kempf, Monique Alric, Stéphanie Blanquet-Diot. Development and validation of a new dynamic in vitro model of the piglet colon (PigutIVM): application to the study of probioticsApplied Microbiology and Biotechnology 2017; 101(6): 2533 doi: 10.1007/s00253-017-8122-y
70
Monique M Elseviers, Yoleen Van Camp, Sander Nayaert, Khyra Duré, Lieven Annemans, Ann Tanghe, Sebastian Vermeersch. Prevalence and management of antibiotic associated diarrhea in general hospitalsBMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-0869-0
71
Annick Lejeune, Philippe Thonart, Frank Delvigne. Stress microbien lors du processus d’extrapolation: Approche physique et biologiqueCerevisia 2013; 38(3): 89 doi: 10.1016/j.cervis.2013.10.002
72
Yehuda Ringel, Eamonn MM Quigley, Henry C Lin. Using Probiotics in Gastrointestinal DisordersThe American Journal of Gastroenterology Supplements 2012; 1(1): 34 doi: 10.1038/ajgsup.2012.7
73
Gerard Mullin. Gastrointestinal and Liver Disease Nutrition Desk Reference2011; : 21 doi: 10.1201/b11184-4
74
Constantinos Karaolis, George Botsaris, Iakovos Pantelides, Dimitris Tsaltas. Potential application ofSaccharomyces boulardiias a probiotic in goat's yoghurt: survival and organoleptic effectsInternational Journal of Food Science & Technology 2013; 48(7): 1445 doi: 10.1111/ijfs.12111
75
S. Lital Meyer, A. Ricardo Espinoza, P. Rodrigo Quera. Infección por clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticasRevista Médica Clínica Las Condes 2014; 25(3): 473 doi: 10.1016/S0716-8640(14)70064-1
76
Swastik Sen, Thomas J. Mansell. Yeasts as probiotics: Mechanisms, outcomes, and future potentialFungal Genetics and Biology 2020; 137: 103333 doi: 10.1016/j.fgb.2020.103333
77
H. Szajewska, A. Horvath, A. Piwowarczyk. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatmentAlimentary Pharmacology & Therapeutics 2010; 32(9): 1069 doi: 10.1111/j.1365-2036.2010.04457.x
78
Muhan LÜ, Shan Yu, Jiaqi Deng, Qiong Yan, Chun Yang, Guodong Xia, Xian Zhou, Anna Roujeinikova. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled TrialsPLOS ONE 2016; 11(10): e0163743 doi: 10.1371/journal.pone.0163743
79
Annika Reintam Blaser, Adam M. Deane, Sonja Fruhwald. Diarrhoea in the critically illCurrent Opinion in Critical Care 2015; 21(2): 142 doi: 10.1097/MCC.0000000000000188
80
Pedro Pais, Vanda Almeida, Melike Yılmaz, Miguel C. Teixeira. Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?Journal of Fungi 2020; 6(2): 78 doi: 10.3390/jof6020078
81
Carlos Jadán-Piedra, Marta Baquedano, Sergi Puig, Dinoraz Vélez, Vicenta Devesa. Use of Saccharomyces cerevisiae To Reduce the Bioaccessibility of Mercury from FoodJournal of Agricultural and Food Chemistry 2017; 65(13): 2876 doi: 10.1021/acs.jafc.7b00285
82
Lorenzo Morelli, Maria Luisa Callegari. Metabolic Syndrome and Complications of Pregnancy2015; : 35 doi: 10.1007/978-3-319-16853-1_3
83
Jürgen Stein, Axel Dignaß. Prävention und Therapie von entzündlichen Magen-/Darm-ErkrankungenPharmazie in unserer Zeit 2012; 41(2): 123 doi: 10.1002/pauz.201100460
84
Judit Villar-García, Robert Güerri-Fernández, Andrés Moya, Alicia González, Juan J. Hernández, Elisabet Lerma, Ana Guelar, Luisa Sorli, Juan P. Horcajada, Alejandro Artacho, Giuseppe D´Auria, Hernando Knobel, Alan Landay. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trialPLOS ONE 2017; 12(4): e0173802 doi: 10.1371/journal.pone.0173802
85
Hania Szajewska, Maciej Kołodziej, Bartłomiej M. Zalewski. Systematic review with meta-analysis:Saccharomyces boulardiifor treating acute gastroenteritis in children-a 2020 updateAlimentary Pharmacology & Therapeutics 2020; 51(7): 678 doi: 10.1111/apt.15659
86
Daniel J. Selig, Jesse P. DeLuca, Qigui Li, Hsiuling Lin, Ken Nguyen, Shaylyn M. Scott, Jason C. Sousa, Chau T. Vuong, Lisa H. Xie, Jeffrey R. Livezey. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillinDrug Metabolism and Personalized Therapy 2020; 0(0) doi: 10.1515/dmpt-2019-0032
87
Marie Ceccarelli, Vanessa Gouyot, Olivier Marty. Endométriose2020; : 179 doi: 10.1016/B978-2-294-76781-4.00018-1
88
Mario Matijašić, Tomislav Meštrović, Hana Čipčić Paljetak, Mihaela Perić, Anja Barešić, Donatella Verbanac. Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBDInternational Journal of Molecular Sciences 2020; 21(8): 2668 doi: 10.3390/ijms21082668
89
M Rauch, SV Lynch. The potential for probiotic manipulation of the gastrointestinal microbiomeCurrent Opinion in Biotechnology 2012; 23(2): 192 doi: 10.1016/j.copbio.2011.11.004
90
Chao-Hung Kuo, Fu-Chen Kuo, Huang-Ming Hu, Chung-Jung Liu, Sophie S. W. Wang, Yen-Hsu Chen, Ming-Chia Hsieh, Ming-Feng Hou, Deng-Chyang Wu. The Optimal First-Line Therapy ofHelicobacter pyloriInfection in Year 2012Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/168361
91
Kerry L Ivey, Jonathan M Hodgson, Susan W Kim, Richard J Woodman, Richard L Prince. Probiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adultsCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD010445.pub2
92
Sukanta Kumar Nayak. ProbioticsMicrobiology Monographs 2011; 21: 29 doi: 10.1007/978-3-642-20838-6_2
93
L. V. McFarland. From Yaks to Yogurt: The History, Development, and Current Use of ProbioticsClinical Infectious Diseases 2015; 60(suppl 2): S85 doi: 10.1093/cid/civ054
94
Paola Brun, Melania Scarpa, Chiara Marchiori, Gloria Sarasin, Valentina Caputi, Andrea Porzionato, Maria Cecilia Giron, Giorgio Palù, Ignazio Castagliuolo, Seungil Ro. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBSPLOS ONE 2017; 12(7): e0181863 doi: 10.1371/journal.pone.0181863
95
R. Ann Hays, Christina Surawicz. Geriatric Gastroenterology2020; : 1 doi: 10.1007/978-3-319-90761-1_71-1
96
Taylor C Wallace, Francisco Guarner, Karen Madsen, Michael D Cabana, Glenn Gibson, Eric Hentges, Mary Ellen Sanders. Human gut microbiota and its relationship to health and diseaseNutrition Reviews 2011; 69(7): 392 doi: 10.1111/j.1753-4887.2011.00402.x
97
Michael Altmann. The Yeast Role in Medical Applications2018;  doi: 10.5772/intechopen.70591
98
Marco Constante, Giada De Palma, Jun Lu, Jennifer Jury, Liam Rondeau, Alberto Caminero, Stephen M. Collins, Elena F. Verdu, Premysl Bercik. Saccharomyces boulardii CNCM I‐745 modulates the microbiota–gut–brain axis in a humanized mouse model of Irritable Bowel Syndrome Neurogastroenterology & Motility 2021; 33(3) doi: 10.1111/nmo.13985
99
Mario Zucca, Sara Scutera, Dianella Savoia. Novel avenues forClostridium difficileinfection drug discoveryExpert Opinion on Drug Discovery 2013; 8(4): 459 doi: 10.1517/17460441.2013.770466
100
Dietary Supplements and Functional Foods2013; : 289 doi: 10.1002/9781118788660.refs
101
Lingfen Xu, Yun Wang, Yang Wang, Jianhua Fu, Mei Sun, Zhiqin Mao, Yvan Vandenplas. A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infantsJornal de Pediatria 2016; 92(3): 296 doi: 10.1016/j.jped.2015.08.013
102
Z.X. He, B. Ferlisi, E. Eckert, H.E. Brown, A. Aguilar, M.A. Steele. Supplementing a yeast probiotic to pre-weaning Holstein calves: Feed intake, growth and fecal biomarkers of gut healthAnimal Feed Science and Technology 2017; 226: 81 doi: 10.1016/j.anifeedsci.2017.02.010
103
Christopher L. Knight, Christina M. Surawicz. Clostridium difficile InfectionMedical Clinics of North America 2013; 97(4): 523 doi: 10.1016/j.mcna.2013.02.003
104
S. Weis, M. Grimm. Nosokomiale DiarrhöDer Internist 2011; 52(2): 167 doi: 10.1007/s00108-010-2789-9
105
L.V. McFarland. The Microbiota in Gastrointestinal Pathophysiology2017; : 145 doi: 10.1016/B978-0-12-804024-9.00018-5
106
Gerard E. Mullin. Probiotics and Digestive DiseaseNutrition in Clinical Practice 2012; 27(2): 300 doi: 10.1177/0884533612439609
107
Filipa F. Vale, Jorge M. B. Vítor, Mónica Oleastro. Helicobacter pylori Research2016; : 543 doi: 10.1007/978-4-431-55936-8_24
108
Jiaojiao Xie, Mingfei Yao, Yanmeng Lu, Mengjia Yu, Shengyi Han, David J. McClements, Hang Xiao, Lanjuan Li. Impact of encapsulating a probiotic (Pediococcus pentosaceus Li05) within gastro-responsive microgels on Clostridium difficile infectionsFood & Function 2021; 12(7): 3180 doi: 10.1039/D0FO03235B
109
Bradley C Johnston, Joshua Z Goldenberg, Per O Vandvik, Xin Sun, Gordon H Guyatt, Bradley C Johnston. Cochrane Database of Systematic Reviews2011;  doi: 10.1002/14651858.CD004827.pub3
110
Margret I Moré, Yvan Vandenplas. Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects ReviewClinical Medicine Insights: Gastroenterology 2018; 11: 117955221775267 doi: 10.1177/1179552217752679
111
Matheus A. S. Santos, Mariana T. C. Machado. Coated alginate–chitosan particles to improve the stability of probiotic yeastInternational Journal of Food Science & Technology 2021; 56(5): 2122 doi: 10.1111/ijfs.14829
112
Mathias L. Richard, Harry Sokol. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseasesNature Reviews Gastroenterology & Hepatology 2019;  doi: 10.1038/s41575-019-0121-2
113
Grégoire Wieërs, Leila Belkhir, Raphaël Enaud, Sophie Leclercq, Jean-Michel Philippart de Foy, Isabelle Dequenne, Philippe de Timary, Patrice D. Cani. How Probiotics Affect the MicrobiotaFrontiers in Cellular and Infection Microbiology 2020; 9 doi: 10.3389/fcimb.2019.00454
114
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterologyRevista de Gastroenterología de México (English Edition) 2017; 82(2): 156 doi: 10.1016/j.rgmxen.2017.03.003
115
Seema Patel. Nutrition, safety, market status quo appraisal of emerging functional food corn smut (huitlacoche)Trends in Food Science & Technology 2016; 57: 93 doi: 10.1016/j.tifs.2016.09.006
116
J. Adam Rindfleisch. Integrative Medicine2012; : 906 doi: 10.1016/B978-1-4377-1793-8.00086-8
117
Rong Zhu, Kan Chen, Yuan-Yuan Zheng, Hua-Wei Zhang, Jun-Shan Wang, Yu-Jing Xia, Wei-Qi Dai, Fan Wang, Miao Shen, Ping Cheng, Yan Zhang, Cheng-Fen Wang, Jing Yang, Jing-Jing Li, Jie Lu, Ying-Qun Zhou, Chuan-Yong Guo. Meta-analysis of the efficacy of probiotics in <italic>Helicobacter pylori</italic> eradication therapyWorld Journal of Gastroenterology 2014; 20(47): 18013-18021 doi: 10.3748/wjg.v20.i47.18013
118
Gustavo Almeida Bastos, Elinalva Maciel Paulo, Ana Cristina Nascimento Chiaradia. Aceitabilidade de barra de cereais potencialmente probióticaBrazilian Journal of Food Technology 2014; 17(2): 113 doi: 10.1590/bjft.2014.012
119
Jeremy Cottrell, Kerstin Koenig, Roland Perfekt, Robert Hofmann. Comparison of Two Forms of Loperamide–Simeticone and a Probiotic Yeast (Saccharomyces boulardii) in the Treatment of Acute Diarrhoea in Adults: A Randomised Non-Inferiority Clinical TrialDrugs in R&D 2015; 15(4): 363 doi: 10.1007/s40268-015-0111-y
120
Christina M Surawicz, Lawrence J Brandt, David G Binion, Ashwin N Ananthakrishnan, Scott R Curry, Peter H Gilligan, Lynne V McFarland, Mark Mellow, Brian S Zuckerbraun. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile InfectionsAmerican Journal of Gastroenterology 2013; 108(4): 478 doi: 10.1038/ajg.2013.4
121
Krankenhaus- und Praxishygiene2016; : 337 doi: 10.1016/B978-3-437-22312-9.00005-6
122
Satyajit Lenka, Deepak Singh, Sandip Paul, Anindita Gayen, Manabendra Chandra. S. boulardii Fails to Hold Its Cell Wall Integrity against Nonpathogenic E. coli: Are Probiotic Yeasts Losing the Battle?ACS Infectious Diseases 2021; 7(4): 733 doi: 10.1021/acsinfecdis.0c00413
123
Jennifer Joan Ryan, Douglas Allen Hanes, Morgan Beth Schafer, Jeremy Mikolai, Heather Zwickey. Effect of the ProbioticSaccharomyces boulardiion Cholesterol and Lipoprotein Particles in Hypercholesterolemic Adults: A Single-Arm, Open-Label Pilot StudyThe Journal of Alternative and Complementary Medicine 2015; 21(5): 288 doi: 10.1089/acm.2014.0063
124
Elena Hadjimbei, George Botsaris, Vlasios Goulas, Eleni Alexandri, Vassilis Gekas, Ioannis P Gerothanassis. Functional stability of goats' milk yoghurt supplemented with Pistacia atlantica resin extracts and Saccharomyces boulardii International Journal of Dairy Technology 2020; 73(1): 134 doi: 10.1111/1471-0307.12629
125
E.C. Dinleyici, A. Kara, N. Dalgic, Z. Kurugol, V. Arica, O. Metin, E. Temur, O. Turel, S. Guven, O. Yasa, S. Bulut, G. Tanir, A.S. Yazar, A. Karbuz, M. Sancar, M. Erguven, G. Akca, M. Eren, M. Ozen, Y. Vandenplas. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoeaBeneficial Microbes 2015; 6(4): 415 doi: 10.3920/BM2014.0086
126
Nuntra Suwantarat, David A. Bobak. Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile InfectionCurrent Infectious Disease Reports 2011; 13(1): 21 doi: 10.1007/s11908-010-0155-7
127
Joshua Z Goldenberg, Stephanie SY Ma, Jane D Saxton, Mark R Martzen, Per O Vandvik, Kristian Thorlund, Gordon H Guyatt, Bradley C Johnston. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and childrenCochrane Database of Systematic Reviews 2013;  doi: 10.1002/14651858.CD006095.pub3
128
C.Q. Tan, H.K. Wei, H.Q. Sun, G. Long, J.T. Ao, S.W. Jiang, J. Peng. Effects of supplementing sow diets during two gestations with konjac flour and Saccharomyces boulardii on constipation in peripartal period, lactation feed intake and piglet performanceAnimal Feed Science and Technology 2015; 210: 254 doi: 10.1016/j.anifeedsci.2015.10.013
129
Sunita Grover, Rashmi H. Mallappa, Virender Kumar Batish. Encyclopedia of Metagenomics2014; : 1 doi: 10.1007/978-1-4614-6418-1_575-2
130
Alyssa M. Parian, Berkeley N. Limketkai, Neha D. Shah, Gerard E. Mullin. Nutraceutical Supplements for Inflammatory Bowel DiseaseNutrition in Clinical Practice 2015; 30(4): 551 doi: 10.1177/0884533615586598
131
Serhan Sakarya, Necati Gunay. Saccharomyces boulardiiexpresses neuraminidase activity selective for α2,3-linked sialic acid that decreasesHelicobacter pyloriadhesion to host cellsAPMIS 2014; 122(10): 941 doi: 10.1111/apm.12237
132
L.R. Hancox, M. Le Bon, P.J. Richards, D. Guillou, C.E.R. Dodd, K.H. Mellits. Effect of a single dose of Saccharomyces cerevisiae var. boulardii on the occurrence of porcine neonatal diarrhoeaAnimal 2015; 9(11): 1756 doi: 10.1017/S1751731114002687
133
H. Szajewska, M. Kołodziej. Systematic review with meta-analysis:Saccharomyces boulardiiin the prevention of antibiotic-associated diarrhoeaAlimentary Pharmacology & Therapeutics 2015; 42(7): 793 doi: 10.1111/apt.13344
134
Gyu Man Oh, Won Moon, Kwang Il Seo, Kyoungwon Jung, Jae Hyun Kim, Sung Eun Kim, Moo In Park, Seun Ja Park. Changes in the Crohn’s Disease Activity Index and Safety of Administering Saccharomyces Boulardii in Patients with Crohn’s Disease in Clinical Remission: A Single Hospital-based Retrospective Cohort StudyThe Korean Journal of Gastroenterology 2020; 76(6): 314 doi: 10.4166/kjg.2020.115
135
Angela Capece, Rossana Romaniello, Angela Pietrafesa, Gabriella Siesto, Rocchina Pietrafesa, Marianna Zambuto, Patrizia Romano. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-addedInternational Journal of Food Microbiology 2018; 284: 22 doi: 10.1016/j.ijfoodmicro.2018.06.028
136
C. Villot, T. Ma, D.L. Renaud, M.H. Ghaffari, D.J. Gibson, A. Skidmore, E. Chevaux, L.L. Guan, M.A. Steele. Saccharomyces cerevisiae boulardii CNCM I-1079 affects health, growth, and fecal microbiota in milk-fed veal calvesJournal of Dairy Science 2019; 102(8): 7011 doi: 10.3168/jds.2018-16149
137
Lynne V. McFarland, Shan Goh. Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: A systematic review and meta-analysisTravel Medicine and Infectious Disease 2019; 27: 11 doi: 10.1016/j.tmaid.2018.09.007
138
Intestinal Microbiota in Health and Disease2014; : 148 doi: 10.1201/b16442-7
139
Anders P. Jensen, Charlotte R. Bjørnvad. Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic reviewJournal of Veterinary Internal Medicine 2019; 33(5): 1849 doi: 10.1111/jvim.15554
140
Ozge Serce, Derya Benzer, Tugba Gursoy, Guner Karatekin, Fahri Ovali. Efficacy of saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: A randomised controlled trialEarly Human Development 2013; 89(12): 1033 doi: 10.1016/j.earlhumdev.2013.08.013
141
Karen Madsen. The International Scientific Conference on Probiotics and PrebioticsExpert Review of Gastroenterology & Hepatology 2011; 5(5): 571 doi: 10.1586/egh.11.61
142
Lynne V McFarland. Emerging therapies forClostridium difficileinfectionsExpert Opinion on Emerging Drugs 2011; 16(3): 425 doi: 10.1517/14728214.2011.571204
143
Diego Currò, Gianluca Ianiro, Silvia Pecere, Stefano Bibbò, Giovanni Cammarota. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disordersBritish Journal of Pharmacology 2017; 174(11): 1426 doi: 10.1111/bph.13632
144
Lorena Vívien Neves de Oliveira, Rafael Wesley Bastos, Noelly de Queiroz Ribeiro, Marliete Carvalho Costa, Leonardo Borges Acurcio, Karen Maia Rocha, Julliana Ribeiro Alves Santos, Rosana de Carvalho Cruz, Betânia Maria Soares, Daniel Assis Santos. In vivo probiotic and antimicrobial photodynamic therapy as alternative therapies against cryptococcosis are ineffectiveVeterinary Microbiology 2017; 211: 169 doi: 10.1016/j.vetmic.2017.08.015
145
Priscilla F. C. Justino, Luis F. M. Melo, Andre F. Nogueira, Jose V. G. Costa, Luara M. N. Silva, Cecila M. Santos, Walber O. Mendes, Marina R. Costa, Alvaro X. Franco, Aldo A. Lima, Ronaldo A. Ribeiro, Marcellus H. L. P. Souza, Pedro M. G. Soares. Treatment withSaccharomyces boulardiireduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in miceBritish Journal of Nutrition 2014; 111(9): 1611 doi: 10.1017/S0007114513004248
146
Amandine Everard, Sébastien Matamoros, Lucie Geurts, Nathalie M. Delzenne, Patrice D. Cani, Martin J. Blaser. Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db MicemBio 2014; 5(3) doi: 10.1128/mBio.01011-14
147
Lynne V. McFarland, Charlesnika T. Evans, Ellie J. C. Goldstein. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-AnalysisFrontiers in Medicine 2018; 5 doi: 10.3389/fmed.2018.00124
148
David L. McCollum, J. Martin Rodriguez. Detection, Treatment, and Prevention of Clostridium difficile InfectionClinical Gastroenterology and Hepatology 2012; 10(6): 581 doi: 10.1016/j.cgh.2012.03.008
149
Lauren E. Hudson, Milo B. Fasken, Courtney D. McDermott, Shonna M. McBride, Emily G. Kuiper, David B. Guiliano, Anita H. Corbett, Tracey J. Lamb, Alvaro Galli. Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardiiPLoS ONE 2014; 9(11): e112660 doi: 10.1371/journal.pone.0112660
150
Harry Sokol, Valentin Leducq, Hugues Aschard, Hang-Phuong Pham, Sarah Jegou, Cecilia Landman, David Cohen, Giuseppina Liguori, Anne Bourrier, Isabelle Nion-Larmurier, Jacques Cosnes, Philippe Seksik, Philippe Langella, David Skurnik, Mathias L Richard, Laurent Beaugerie. Fungal microbiota dysbiosis in IBDGut 2017; 66(6): 1039 doi: 10.1136/gutjnl-2015-310746
151
P. Trevisi, R. Latorre, D. Priori, D. Luise, I. Archetti, M. Mazzoni, R. D’Inca, P. Bosi. Effect of feed supplementation with live yeast on the intestinal transcriptome profile of weaning pigs orally challenged with Escherichia coli F4Animal 2017; 11(1): 33 doi: 10.1017/S1751731116001178
152
Madhu S. Malo, Omeed Moaven, Nur Muhammad, Brishti Biswas, Sayeda N. Alam, Konstantinos P. Economopoulos, Sarah Shireen Gul, Sulaiman R. Hamarneh, Nondita S. Malo, Abeba Teshager, Mussa M. Rafat Mohamed, Qingsong Tao, Sonoko Narisawa, José Luis Millán, Elizabeth L. Hohmann, H. Shaw Warren, Simon C. Robson, Richard A. Hodin. Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphatesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 306(10): G826 doi: 10.1152/ajpgi.00357.2013
153
S.C. Chandrasekar Rajendran, B. Chamlagain, S. Kariluoto, V. Piironen, P.E.J. Saris. Biofortification of riboflavin and folate in idli batter, based on fermented cereal and pulse, byLactococcus lactisN8 andSaccharomyces boulardiiSAA655Journal of Applied Microbiology 2017; 122(6): 1663 doi: 10.1111/jam.13453
154
Jonathan Thévenot, Lucie Etienne-Mesmin, Sylvain Denis, Sandrine Chalancon, Monique Alric, Valérie Livrelli, Stéphanie Blanquet-Diot. Enterohemorrhagic Escherichia coli O157:H7 Survival in anIn VitroModel of the Human Large Intestine and Interactions with Probiotic Yeasts and Resident MicrobiotaApplied and Environmental Microbiology 2013; 79(3): 1058 doi: 10.1128/AEM.03303-12
155
Lingfen Xu, Yun Wang, Yang Wang, Jianhua Fu, Mei Sun, Zhiqin Mao, Yvan Vandenplas. A double‐blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I‐745 in formula‐fed preterm infantsJornal de Pediatria (Versão em Português) 2016; 92(3): 296 doi: 10.1016/j.jpedp.2016.03.004
156
F.C.P. Tiago, B.A.A. Porto, N.S. Ribeiro, L.M.C. Moreira, R.M.E. Arantes, A.T. Vieira, M.M. Teixeira, S.V. Generoso, V.N. Nascimento, F.S. Martins, J.R. Nicoli. Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel diseaseBeneficial Microbes 2015; 6(6): 807 doi: 10.3920/BM2015.0018
157
Amir Saber, Beitollah Alipour, Zeinab Faghfoori, Ahmad Yari Khosroushahi. Cellular and molecular effects of yeast probiotics on cancerCritical Reviews in Microbiology 2017; 43(1): 96 doi: 10.1080/1040841X.2016.1179622
158
Alice Vilela, Fernanda Cosme, António Inês. Wine and Non-Dairy Fermented Beverages: A Novel Source of Pro- and PrebioticsFermentation 2020; 6(4): 113 doi: 10.3390/fermentation6040113
159
Qin Guo, Joshua Z Goldenberg, Claire Humphrey, Regina El Dib, Bradley C Johnston. Probiotics for the prevention of pediatric antibiotic-associated diarrheaCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD004827.pub5
160
Mélanie G. Gareau, Philip M. Sherman, W. Allan Walker. Probiotics and the gut microbiota in intestinal health and diseaseNature Reviews Gastroenterology & Hepatology 2010; 7(9): 503 doi: 10.1038/nrgastro.2010.117
161
Jeppe West Carstensen, Mahtab Chehri, Kristian Schønning, Steen Christian Rasmussen, Jacob Anhøj, Nina Skavlan Godtfredsen, Christian Østergaard Andersen, Andreas Munk Petersen. Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention studyEuropean Journal of Clinical Microbiology & Infectious Diseases 2018; 37(8): 1431 doi: 10.1007/s10096-018-3267-x
162
A. G. Boyle, K. G. Magdesian, R. Gallop, S. Sigdel, M. M. Durando. Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhoeaVeterinary Record 2013; 172(5): 128 doi: 10.1136/vr.100833
163
Nancy Awasti, Santosh Anand. Dairy Processing: Advanced Research to Applications2020; : 243 doi: 10.1007/978-981-15-2608-4_12
164
Abhijit Banik, Joy Mondal, Subham Rakshit, Kuntal Ghosh, Shankar Prasad Sha, Suman Kumar Halder, Chandradipa Ghosh, Keshab Chandra Mondal. Amelioration of cold-induced gastric injury by a yeast probiotic isolated from traditional fermented foodsJournal of Functional Foods 2019; 59: 164 doi: 10.1016/j.jff.2019.05.039
165
Geoffrey A. Preidis, Colin Hill, Richard L. Guerrant, B.S. Ramakrishna, Gerald W. Tannock, James Versalovic. Probiotics, Enteric and Diarrheal Diseases, and Global HealthGastroenterology 2011; 140(1): 8 doi: 10.1053/j.gastro.2010.11.010
166
Christoph G Dietrich, Tanja Kottmann, Manuela Alavi. Commercially available probiotic drinks containing <italic>Lactobacillus casei</italic> DN-114001 reduce antibiotic-associated diarrheaWorld Journal of Gastroenterology 2014; 20(42): 15837-15844 doi: 10.3748/wjg.v20.i42.15837
167
Ener Cagri Dinleyici, Makbule Eren, Metehan Ozen, Zeynel Abidin Yargic, Yvan Vandenplas. Effectiveness and safety ofSaccharomyces boulardiifor acute infectious diarrheaExpert Opinion on Biological Therapy 2012; 12(4): 395 doi: 10.1517/14712598.2012.664129
168
Simona D'Angelo, Federico Fracassi, Francesca Bresciani, Roberta Galuppi, Alessia Diana, Nikolina Linta, Giuliano Bettini, Maria Morini, Marco Pietra. Effect of Saccharomyces boulardii in dogs with chronic enteropathies: double-blinded, placebo-controlled studyVeterinary Record 2018; 182(9): 258 doi: 10.1136/vr.104241
169
Kevin Chen, Yixuan Zhu, Yongrong Zhang, Therwa Hamza, Hua Yu, Ashley Saint Fleur, James Galen, Zhiyong Yang, Hanping Feng. A probiotic yeast-based immunotherapy against Clostridioides difficile infectionScience Translational Medicine 2020; 12(567): eaax4905 doi: 10.1126/scitranslmed.aax4905
170
Sahil Khanna, Darrell S. Pardi. Clostridium difficile infection: management strategies for a difficult diseaseTherapeutic Advances in Gastroenterology 2014; 7(2): 72 doi: 10.1177/1756283X13508519
171
Pilar Calo-Mata, Jose Manuel Ageitos, Karola Böhme, Jorge Barros-Velázquez. New Weapons to Control Bacterial Growth2016; : 281 doi: 10.1007/978-3-319-28368-5_12
172
Marcella Lobato D. Consoli, Raphael Steinberg da Silva, Jacques Robert Nicoli, Oscar Bruña-Romero, Rodrigo Gomes da Silva, Simone de Vasconcelos Generoso, Maria Isabel T. D. Correia. Randomized Clinical TrialJournal of Parenteral and Enteral Nutrition 2016; 40(8): 1114 doi: 10.1177/0148607115584387
173
K.S. Divya, S. Mahadeva Murthy, Sudisha Jogaiah. Biocontrol Agents and Secondary Metabolites2021; : 631 doi: 10.1016/B978-0-12-822919-4.00027-2
174
Kelly A. Mulholland, Monique G. Robinson, Sharon J. Keeler, Timothy J. Johnson, Bonnie W. Weber, Calvin L. Keeler. Metagenomic Analysis of the Respiratory Microbiome of a Broiler Flock from Hatching to ProcessingMicroorganisms 2021; 9(4): 721 doi: 10.3390/microorganisms9040721
175
Matthew L. Wheeler, Jose J. Limon, David M. Underhill. Immunity to Commensal Fungi: Detente and DiseaseAnnual Review of Pathology: Mechanisms of Disease 2017; 12(1): 359 doi: 10.1146/annurev-pathol-052016-100342
176
Hannah D. Holscher. Diet Affects the Gastrointestinal Microbiota and HealthJournal of the Academy of Nutrition and Dietetics 2020; 120(4): 495 doi: 10.1016/j.jand.2019.12.016
177
C Stevenson, R Blaauw. Probiotics, with special emphasis on their role in the management of irritable bowel syndromeSouth African Journal of Clinical Nutrition 2011; 24(2): 63 doi: 10.1080/16070658.2011.11734353
178
Iyad Issa, Rami Moucari. Probiotics for antibiotic-associated diarrhea: Do we have a verdict?World Journal of Gastroenterology 2014; 20(47): 17788-17795 doi: 10.3748/wjg.v20.i47.17788
179
Joshua Z Goldenberg, Lyubov Lytvyn, Justin Steurich, Patricia Parkin, Sanjay Mahant, Bradley C Johnston. Probiotics for the prevention of pediatric antibiotic-associated diarrheaCochrane Database of Systematic Reviews 2015;  doi: 10.1002/14651858.CD004827.pub4
180
Przemysław Gałązka, Aleksandra Baska, Jakub Kazik, Kamil Leis. SACCHAROMYCES CEREVISIAE VAR. BOULARDII IN IRRITABLE BOWEL SYNDROMEPostępy Mikrobiologii - Advancements of Microbiology 2020; 59(1): 39 doi: 10.21307/PM-2020.59.1.004
181
A. S. Sarsenbaeva, L. B. Lazebnik. Features of intestinal damage in COVID-19Experimental and Clinical Gastroenterology 2020; (12): 16 doi: 10.31146/1682-8658-ecg-184-12-16-22
182
Morgambal Padayachee, Janicke Visser, Estelle Viljoen, Alfred Musekiwa, Renée Blaauw. Efficacy and safety of Saccharomyces boulardii in the treatment of acute gastroenteritis in the paediatric population: a systematic reviewSouth African Journal of Clinical Nutrition 2019; 32(3): 58 doi: 10.1080/16070658.2018.1449378
183
Michał Seweryn Karbownik, Joanna Kręczyńska, Paulina Kwarta, Magdalena Cybula, Anna Wiktorowska-Owczarek, Edward Kowalczyk, Tadeusz Pietras, Janusz Szemraj. Effect of Supplementation with Saccharomyces Boulardii on Academic Examination Performance and Related Stress in Healthy Medical Students: A Randomized, Double-Blind, Placebo-Controlled TrialNutrients 2020; 12(5): 1469 doi: 10.3390/nu12051469
184
C. Villot, Y. Chen, K. Pedgerachny, F. Chaucheyras-Durand, E. Chevaux, A. Skidmore, L.L. Guan, M.A. Steele. Early supplementation of Saccharomyces cerevisiae boulardii CNCM I-1079 in newborn dairy calves increases IgA production in the intestine at 1 week of ageJournal of Dairy Science 2020; 103(9): 8615 doi: 10.3168/jds.2020-18274
185
Johnathan Sheele, Jessica Cartowski, Angela Dart, Arjun Poddar, Shikha Gupta, Eric Stashko, Bhaskara S. Ravi, Crawford Nelson, Ajay Gupta. Saccharomyces boulardiiand bismuth subsalicylate as low-cost interventions to reduce the duration and severity of choleraPathogens and Global Health 2015; 109(6): 275 doi: 10.1179/2047773215Y.0000000028
186
H. Szajewska, A. Horvath, M. Kołodziej. Systematic review with meta-analysis:Saccharomyces boulardiisupplementation and eradication ofHelicobacter pyloriinfectionAlimentary Pharmacology & Therapeutics 2015; 41(12): 1237 doi: 10.1111/apt.13214
187
Min-Kyoung Shin, Han Sang Yoo. Animal vaccines based on orally presented yeast recombinantsVaccine 2013; 31(40): 4287 doi: 10.1016/j.vaccine.2013.07.029
188
Nienke van Staaveren, Julia Krumma, Paul Forsythe, Joergen B. Kjaer, Isabelle Y. Kwon, Yu-Kang Mao, Christine West, Wolfgang Kunze, Alexandra Harlander-Matauschek. Cecal motility and the impact of Lactobacillus in feather pecking laying hensScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-69928-6
189
Isabella W. Martin, Rita Tonner, Julie Trivedi, Heather Miller, Richard Lee, Xinglun Liang, Leo Rotello, Elena Isenbergh, Jennifer Anderson, Trish Perl, Sean X. Zhang. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's useDiagnostic Microbiology and Infectious Disease 2017; 87(3): 286 doi: 10.1016/j.diagmicrobio.2016.12.004
190
Lena M. Napolitano, Charles E. Edmiston. Clostridium difficile disease: Diagnosis, pathogenesis, and treatment updateSurgery 2017; 162(2): 325 doi: 10.1016/j.surg.2017.01.018
191
Tieraona Low Dog. Smart Talk on Supplements and Botanicals: Pre- and Post-Operative Surgical CareAlternative and Complementary Therapies 2010; 16(3): 124 doi: 10.1089/act.2010.16312
192
J. Scott Weese. Equine Infectious Diseases2014; : 352 doi: 10.1016/B978-1-4557-0891-8.00041-5
193
Dawood Aghamohammadi, Hormoz Ayromlou, Neda Dolatkhah, Fatemeh Jahanjoo, Seyed Kazem Shakouri. The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trialTrials 2019; 20(1) doi: 10.1186/s13063-019-3454-9
194
Mohamed Sageer, Amy Barto. Recurrent Clostridium difficile infection: The scope of the problem and management decisionsSeminars in Colon and Rectal Surgery 2014; 25(3): 158 doi: 10.1053/j.scrs.2014.05.012
195
Katarzyna B. Hooks, Maureen A. O'Malley. Contrasting Strategies: Human Eukaryotic Versus Bacterial Microbiome ResearchJournal of Eukaryotic Microbiology 2020; 67(2): 279 doi: 10.1111/jeu.12766
196
Zhang Bin, Xu Ya-Zheng, Deng Zhao-Hui, Chu Bo, Jiang Li-Rong, Yvan Vandenplas. The Efficacy ofSaccharomyces boulardiiCNCM I-745 in Addition to StandardHelicobacter pyloriEradication Treatment in ChildrenPediatric Gastroenterology, Hepatology & Nutrition 2015; 18(1): 17 doi: 10.5223/pghn.2015.18.1.17
197
J.F. Garcia-Mazcorro, S.L. Ishaq, M.V. Rodriguez-Herrera, C.A. Garcia-Hernandez, J.R. Kawas, T.G. Nagaraja. Review: Are there indigenous Saccharomyces in the digestive tract of livestock animal species? Implications for health, nutrition and productivity traitsAnimal 2020; 14(1): 22 doi: 10.1017/S1751731119001599
198
Barbara C Olendzki, Taryn D Silverstein, Gioia M Persuitte, Yunsheng Ma, Katherine R Baldwin, David Cave. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series reportNutrition Journal 2014; 13(1) doi: 10.1186/1475-2891-13-5
199
Dana D. Byrne, Annette C. Reboli. Rare Yeast Infections: Risk Factors, Clinical Manifestations, Treatment, and Special ConsiderationsCurrent Clinical Microbiology Reports 2017; 4(4): 218 doi: 10.1007/s40588-017-0073-7
200
Ida M. Smith, Jeffrey E. Christensen, Nils Arneborg, Lene Jespersen, Junji Yodoi. Yeast Modulation of Human Dendritic Cell Cytokine Secretion: An In Vitro StudyPLoS ONE 2014; 9(5): e96595 doi: 10.1371/journal.pone.0096595
201
Maria Theodorakopoulou, Elias Perros, Evangelos J. Giamarellos-Bourboulis, George Dimopoulos. Controversies in the management of the critically ill: the role of probioticsInternational Journal of Antimicrobial Agents 2013; 42: S41 doi: 10.1016/j.ijantimicag.2013.04.010
202
Rodolphe Pontier-Bres, Patrick Munro, Laurent Boyer, Rodolphe Anty, Véronique Imbert, Chloé Terciolo, Fréderic André, Patrick Rampal, Emmanuel Lemichez, Jean-François Peyron, Dorota Czerucka, Stefan Bereswill. Saccharomyces boulardii Modifies Salmonella Typhimurium Traffic and Host Immune Responses along the Intestinal TractPLoS ONE 2014; 9(8): e103069 doi: 10.1371/journal.pone.0103069
203
Vandana Bharat Patravale, Amita Keertimaan Joshi. Nutraceutical and Functional Foods in Disease PreventionAdvances in Human Services and Public Health 2019; : 1 doi: 10.4018/978-1-5225-3267-5.ch001
204
Victor O. Badger, Nate A. Ledeboer, Mary Beth Graham, Charles E. Edmiston. Clostridium difficileJournal of Parenteral and Enteral Nutrition 2012; 36(6): 645 doi: 10.1177/0148607112446703
205
Angelika Pirker, Alexander Stockenhuber, Marlene Remely, Anna Harrant, Berit Hippe, Christoph Kamhuber, Krista Adelmann, Felix Stockenhuber, Alexander G. Haslberger. Effects of antibiotic therapy on the gastrointestinal microbiota and the influence ofLactobacillus caseiFood and Agricultural Immunology 2013; 24(3): 315 doi: 10.1080/09540105.2012.689816
206
Beata Sulik-Tyszka, Emilian Snarski, Magda Niedźwiedzka, Małgorzata Augustyniak, Thorvald Nilsen Myhre, Anna Kacprzyk, Ewa Swoboda-Kopeć, Marta Roszkowska, Jadwiga Dwilewicz-Trojaczek, Wiesław Wiktor Jędrzejczak, Marta Wróblewska. Experience with Saccharomyces boulardii Probiotic in Oncohaematological PatientsProbiotics and Antimicrobial Proteins 2018; 10(2): 350 doi: 10.1007/s12602-017-9332-4
207
Janice Walton, Denise Burns, Kay E. Gaehle. Process and Outcome of Fecal Microbiota Transplants in Patients With Recurrent Clostridium difficile InfectionGastroenterology Nursing 2017; 40(5): 411 doi: 10.1097/SGA.0000000000000233
208
Ener Cagri Dinleyici, Ates Kara, Metehan Ozen, Yvan Vandenplas. Saccharomyces boulardiiCNCM I-745 in different clinical conditionsExpert Opinion on Biological Therapy 2014; 14(11): 1593 doi: 10.1517/14712598.2014.937419
209
Lynne Vernice McFarland, Metehan Ozen, Ener Cagri Dinleyici, Shan Goh. Comparison of pediatric and adult antibiotic-associated diarrhea and <i>Clostridium difficile</i> infectionsWorld Journal of Gastroenterology 2016; 22(11): 3078-3104 doi: 10.3748/wjg.v22.i11.3078
210
Anastasia Nijnik. Immunomodulatory approaches for prevention and treatment of infectious diseasesCurrent Opinion in Microbiology 2013; 16(5): 590 doi: 10.1016/j.mib.2013.06.011
211
Ida M. Smith, Adam Baker, Jeffrey E. Christensen, Teun Boekhout, Hanne Frøkiær, Nils Arneborg, Lene Jespersen, Ilse D. Jacobsen. Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In VitroPLOS ONE 2016; 11(11): e0167410 doi: 10.1371/journal.pone.0167410
212
S. Shamekhi, H. Lotfi, J. Abdolalizadeh, E. Bonabi, N. Zarghami. An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancerClinical and Translational Oncology 2020; 22(8): 1227 doi: 10.1007/s12094-019-02270-0
213
Sultan Arslan, Mustafa Erbas, Ismail Tontul, Ayhan Topuz. Microencapsulation of probiotic Saccharomyces cerevisiae var. boulardii with different wall materials by spray dryingLWT - Food Science and Technology 2015; 63(1): 685 doi: 10.1016/j.lwt.2015.03.034
214
Alexander Rapoport. Biotechnology of Yeasts and Filamentous Fungi2017; : 87 doi: 10.1007/978-3-319-58829-2_4
215
Rebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib, Katri Korpela, Seppo Virtanen, Taina Sipponen, Anne Salonen, Päivi Saavalainen, Eija Nissilä. Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2020;  doi: 10.1093/ecco-jcc/jjaa252
216
H. Szajewska, M. Kołodziej. Systematic review with meta-analysis:Lactobacillus rhamnosusGG in the prevention of antibiotic-associated diarrhoea in children and adultsAlimentary Pharmacology & Therapeutics 2015; 42(10): 1149 doi: 10.1111/apt.13404
217
Valeria Agamennone, Cyrille A. M. Krul, Ger Rijkers, Remco Kort. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The NetherlandsBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0831-x
218
Charlotte Cordonnier, Jonathan Thévenot, Lucie Etienne-Mesmin, Sylvain Denis, Monique Alric, Valérie Livrelli, Stéphanie Blanquet-Diot. Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut MicrobiotaMicroorganisms 2015; 3(4): 725 doi: 10.3390/microorganisms3040725
219
Junsang Hwang, Ina Bang, Donghyuk Kim, Seung Chul Shin, Young-Wook Chin, Tae-Wan Kim, Hyo Jin Kim. Genome sequence of the potential probiotic eukaryote Saccharomyces cerevisiae KCCM 512993 Biotech 2020; 10(4) doi: 10.1007/s13205-020-02174-9
220
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardiiMeditsinskiy sovet = Medical Council 2020; (5): 104 doi: 10.21518/2079-701X-2020-5-104-112
221
Philippe Veisseire, Muriel Bonnet, Taous Saraoui, Cyril Poupet, Olivier Camarès, Marylise Gachinat, Cécile Callon, Guy Febvre, Christophe Chassard, Stéphanie Bornes. Investigation into In Vitro and In Vivo Caenorhabditis elegans Models to Select Cheese Yeasts as Probiotic Candidates for their Preventive Effects against Salmonella TyphimuriumMicroorganisms 2020; 8(6): 922 doi: 10.3390/microorganisms8060922
222
Lee E. Morrow, Vijaya Gogineni, Mark A. Malesker. Probiotic, prebiotic, and synbiotic use in critically ill patientsCurrent Opinion in Critical Care 2012; 18(2): 186 doi: 10.1097/MCC.0b013e3283514b17
223
Zaigham Abbas, Javed Yakoob, Wasim Jafri, Zubair Ahmad, Zahid Azam, Muhammad W. Usman, Sara Shamim, Muhammad Islam. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndromeEuropean Journal of Gastroenterology & Hepatology 2014; 26(6): 630 doi: 10.1097/MEG.0000000000000094
224
Lidia Ibáñez, Rodolphe Pontier-Bres, Frederic Larbret, Akila Rekima, Valérie Verhasselt, Claudine Blin-Wakkach, Dorota Czerucka. Saccharomyces boulardii Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following Salmonella Typhimurium InfectionFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00643
225
Dan He, Hai-Yang Wang, Jing-Yan Feng, Ming-Ming Zhang, Yong Zhou, Xiao-Ting Wu. Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: A meta-analysis of randomized controlled trialsClinics and Research in Hepatology and Gastroenterology 2013; 37(4): 406 doi: 10.1016/j.clinre.2012.10.007
226
Jean L. Schoeni. Compendium of Methods for the Microbiological Examination of Foods2015;  doi: 10.2105/MBEF.0222.025
227
O. Ellouze, V. Berthoud, M. Mervant, J.P. Parthiot, C. Girard. Septic shock due to Saccharomyces boulardiiMédecine et Maladies Infectieuses 2016; 46(2): 104 doi: 10.1016/j.medmal.2015.12.003
228
Eamonn MM Quigley. Gut microbiota and the role of probiotics in therapyCurrent Opinion in Pharmacology 2011; 11(6): 593 doi: 10.1016/j.coph.2011.09.010
229
L. V. McFarland. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic reviewBMJ Open 2014; 4(8): e005047 doi: 10.1136/bmjopen-2014-005047
230
Themistoklis Katsimichas, Alexios S Antonopoulos, Alexandros Katsimichas, Tomohito Ohtani, Yasushi Sakata, Dimitris Tousoulis. The intestinal microbiota and cardiovascular diseaseCardiovascular Research 2019; 115(10): 1471 doi: 10.1093/cvr/cvz135
231
Deniz Güney Duman, Zarife Nigâr Özdemir Kumral, Feriha Ercan, Mustafa Deniz, Güray Can, Berrak Çağlayan Yeğen. Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in ratsBritish Journal of Nutrition 2013; 110(3): 493 doi: 10.1017/S000711451200517X
232
Mariana L. Palma, Daniel Zamith-Miranda, Flaviano S. Martins, Fernando A. Bozza, Leonardo Nimrichter, Mônica Montero-Lomeli, Ernesto T. A. Marques, Bruno Douradinha. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?Applied Microbiology and Biotechnology 2015; 99(16): 6563 doi: 10.1007/s00253-015-6776-x
233
Katarzyna Roeske, Aleksandra Zasuń, Justyna Cieślik, Marta Wróblewska, Tomasz Jagielski. SACCHAROMYCES CEREVISIAEVAR.BOULARDIIPROBIOTIC YEASTS AS ETIOLOGICAL AGENTS OF OPORTUNISTIC INFECTIONS IN HUMANSPostępy Mikrobiologii - Advancements of Microbiology 2020; 59(3): 291 doi: 10.21307/PM-2020.59.3.21
234
S J M Ten Bruggencate, S A Girard, E G M Floris-Vollenbroek, R Bhardwaj, T A Tompkins. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention studyEuropean Journal of Clinical Nutrition 2015; 69(3): 385 doi: 10.1038/ejcn.2014.238
235
Fernanda Silva Farinazzo, Eduardo Silva Farinazzo, Wilma Aparecida Spinosa, Sandra Garcia. Saccharomyces boulardii: Optimization of simultaneous saccharification and fermentation of cell production in organic and conventional apple substrate pulpFood Science and Biotechnology 2017; 26(4): 969 doi: 10.1007/s10068-017-0123-1
236
Patrick Alexander Wachholz, Paulo José Fortes Villas Boas, Vânia dos Santos Nunes. Probiotics, Prebiotics, and Synbiotics2016; : 661 doi: 10.1016/B978-0-12-802189-7.00050-2
237
Abhijit Banik, Suman Kumar Halder, Chandradipa Ghosh, Keshab Chandra Mondal. Recent Advancement in White Biotechnology Through FungiFungal Biology 2019; : 101 doi: 10.1007/978-3-030-14846-1_3
238
Theodoros Kelesidis, Charalabos Pothoulakis. Efficacy and safety of the probioticSaccharomyces boulardiifor the prevention and therapy of gastrointestinal disordersTherapeutic Advances in Gastroenterology 2012; 5(2): 111 doi: 10.1177/1756283X11428502
239
Vanessa Liévin-Le Moal. A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LBTherapeutic Advances in Gastroenterology 2016; 9(1): 57 doi: 10.1177/1756283X15602831
240
João Inácio, Heide-Marie Daniel. Yeasts in Natural Ecosystems: Ecology2017; : 211 doi: 10.1007/978-3-319-61575-2_8
241
Abdul Arif Khan, Mohsin Khurshid, Shahanavaj Khan, Aws Alshamsan. Gut Microbiota and Probiotics: Current Status and Their Role in Cancer TherapeuticsDrug Development Research 2013; 74(6): 365 doi: 10.1002/ddr.21087